AMELIA MAASS: Open Payments
NPI 1366488348 · WEST JORDAN, UT. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,382 in 87 payments from 21 companies in 2025. Trend: 2023 $1,526 · 2024 $1,349 · 2025 $1,382
Food & beverage: $1,382
| Company | Payments | Amount |
|---|---|---|
| ABBVIE INC. | 23 | $291 |
| Amgen Inc. | 18 | $249 |
| PFIZER INC. | 11 | $170 |
| Astellas Pharma US Inc | 6 | $124 |
| GlaxoSmithKline, LLC. | 4 | $66 |
| ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | 3 | $56 |
| Grifols USA, LLC | 2 | $55 |
| Axsome Therapeutics, Inc. | 3 | $54 |
| Abbott Laboratories | 2 | $45 |
| Bayer Healthcare Pharmaceuticals Inc. | 2 | $36 |
Products named: NURTEC ODT, EVENITY, VRAYLAR, Veozah, UBRELVY, OTEZLA, QULIPTA, CAPLYTA.
Industry payments across UT — which companies pay providers there.
